CROWDSTRIKE HLD. DL-,0005/ US22788C1053 /
30/05/2024 08:47:59 | Var. +0.15 | Volume | Denaro08:47:59 | Lettera08:47:59 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
320.15EUR | +0.05% | - Fatturato: - |
320.15Quantità in denaro: - | 321.40Quantità in lettera: - | 78.27 bill.EUR | - | - |
GlobeNewswire
08:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
08:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
08:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
08:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
08:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents